Atea plunges after COVID-19 treatment fails to help patients in study
Go back to Atea plunges after COVID-19 treatment fails to help patients in study| (NASDAQ: AVIR) | Delayed: 4.78 +0.13 (2.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.65 | 52 Week High | $2.00 | |||
| Open | $4.68 | 52 Week Low | $1.15 | |||
| Day High | $4.79 | P/E | N/A | |||
| Day Low | $4.63 | EPS | $0.00 | |||
| Volume | 472,559 | |||||

